(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PATHOQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PATHOQ

ST13

US500000079413517

Class

1, 5, 42

Filing

79413517

Registration

8026609

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

06/25/2026

Trademark type

Combined

Nice classes

1, 5, 42

Filing date

09/30/2024

Registration date

11/18/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/18/2025

Last transaction

06/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

CN

Examiner

SUAREZ, MARIA VICTORIA

Law office

O60

Current location

TMO LAW OFFICE 133

Mark description

The mark consists of the letters "PATHOQ" in plain block text, with the first letter "P" and the last letter "Q" in capital letters and the remaining letters in lower case.

Holders and representatives

Holders

Wuhan ABclonal Biotechnology Co., Ltd.

Representatives

Kevin L. Russell CHERNOFF VILHAUER LLP

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Enzyme preparations for industrial purposes; chemical preparations for scientific purposesother than for medical or veterinary use; chemical preparations for analyses in laboratoriesother than for medical or veterinary purposes; diagnostic preparationsother than for medical or veterinary purposes; biological preparationsother than for medical or veterinary purposesbiological preparations for use in industry and sciencebiological preparation for use in cell cultures other than for medical or veterinary use; bacteriological preparationsbacteriological culture mediums other than for medical and veterinary use; biological tissue culturesother than for medical or veterinary purposes; preparations of microorganismsother than for medical and veterinary use; biochemical catalysts; reagent paperother than for medical or veterinary purposes

Class 5

Reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; cultures of microorganisms for medical or veterinary use; bacteriological preparations for medical and veterinary use; bacterial preparations for medical and veterinary use; biological preparations for medical purposesbiological preparations for the treatment of cancerbiological preparations for use in cell cultures for medical purposesbiological preparations for the treatment of immune system related diseases and disorders; chemical preparations for medical purposeschemical preparations for the treatment of cancer; chemical preparations for medical purposeschemical preparations for sanitary use; chemical preparations for medical purposeschemical preparations for the diagnosis of tumorsreproductive and immune system related diseases and disorders; enzyme preparations for medical purposes; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes

Class 42

Research and development of new products for others; technological research in the field of DNA sequencing; technological research in the field of cell engineering technology; scientific and technological servicestechnological research on tumors and tumor microenvironmentimmunologysignaling pathwaysmolecular biologycell biology in the life science research field; chemical analysis; chemistry servicesresearch and development in the field of chemistry; chemical research; bacteriological research; biological research; conducting clinical trials for others; medical research; Medical research laboratories

Publications

History of USPTO decisions and trademark events.

35 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/25/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/06/2026

FIMP

FINAL DISPOSITION PROCESSED

06/05/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/14/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/14/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/14/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/18/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/18/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

11/18/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/30/2025

PUBO

PUBLISHED FOR OPPOSITION

09/30/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/24/2025

RFNP

REFUSAL PROCESSED BY IB

08/29/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/29/2025

ATRV

ATTORNEY REVIEW COMPLETED

08/29/2025

CREV

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

08/29/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/26/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/26/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/26/2025

CNRT

NON-FINAL ACTION WRITTEN

07/31/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/23/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/23/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/23/2025

DOCK

ASSIGNED TO EXAMINER

06/23/2025

RFNT

REFUSAL PROCESSED BY IB

05/31/2025

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

05/23/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/07/2025

RFRR

REFUSAL PROCESSED BY MPU

05/07/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/20/2025

CNRT

NON-FINAL ACTION WRITTEN

03/19/2025

DOCK

ASSIGNED TO EXAMINER

03/19/2025

MAFR

APPLICATION FILING RECEIPT MAILED

01/14/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/13/2025

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

01/13/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/02/2025

Continuous trademark protection

Get notified about every new filing that threatens PATHOQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.